Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002939619 | SCV003663595 | uncertain significance | Inborn genetic diseases | 2022-11-10 | criteria provided, single submitter | clinical testing | The c.413C>G (p.A138G) alteration is located in exon 1 (coding exon 1) of the SLC30A10 gene. This alteration results from a C to G substitution at nucleotide position 413, causing the alanine (A) at amino acid position 138 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |